Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.

Signals originating from cancer-associated fibroblasts (CAF) may positively regulate proliferation and tumorigenicity in prostate cancer. In this study, we investigated whether CAFs may regulate the biology of prostate cancer stem cells (CSC) by using a conditional Pten deletion mouse model of prostate adenocarcinoma to isolate both CAF cultures and CSC-enriched cell fractions from the tumors. CSCs that were isolated possessed self-renewal, spheroid-forming, and multipotential differentiation activities in tissue culture, segregating with a cell fraction exhibiting a signature expression phenotype, including SCA-1 (high), CD49f (high), CK5 (high), p63 (high), Survivin (high), RUNX2 (high), CD44 (low), CD133 (low), CK18 (low), and Androgen Receptor (low). CSC spheroid-forming efficiency was differentially influenced by the nature of fibroblasts in a coculture system: Compared with mouse urogenital sinus mesenchyme or normal prostate fibroblasts, CAFs enhanced spheroid formation, with the spheroids displaying generally larger sizes and more complex histology. Graft experiments showed that CSCs admixed with CAFs produced prostatic glandular structures with more numerous lesions, high proliferative index, and tumor-like histopathologies, compared with those formed in the presence of normal prostate fibroblasts. Together, our findings underscore a significant role of CAFs in CSC biology.

[1]  R. Weinberg,et al.  Cancer stem cells: mirage or reality? , 2009, Nature Medicine.

[2]  A. Tsujimura,et al.  Prostate stem cells: The niche and cell markers , 2008, International journal of urology : official journal of the Japanese Urological Association.

[3]  O. Witte,et al.  The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Hayward,et al.  Role of the stromal microenvironment in carcinogenesis of the prostate , 2003, International journal of cancer.

[6]  C. Zhong,et al.  Runx2 regulates survivin expression in prostate cancer cells , 2009, Laboratory Investigation.

[7]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[8]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[9]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[10]  I. Weissman,et al.  Therapeutic implications of cancer stem cells. , 2004, Current opinion in genetics & development.

[11]  Chun-Peng Liao,et al.  Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium , 2008, Proceedings of the National Academy of Sciences.

[12]  Kornelia Polyak,et al.  Microenvironmental regulation of cancer development. , 2008, Current opinion in genetics & development.

[13]  L. Johnston,et al.  Competitive Interactions Between Cells: Death, Growth, and Geography , 2009, Science.

[14]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[15]  S. Groshen,et al.  Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. , 2007, Human pathology.

[16]  K. Leong,et al.  Generation of a prostate from a single adult stem cell , 2008, Nature.

[17]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[18]  Haiyan I. Li,et al.  Purification and unique properties of mammary epithelial stem cells , 2006, Nature.

[19]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[20]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[21]  Robert A. Weinberg,et al.  Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.

[22]  D. Altieri,et al.  Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. , 2006, Cancer research.

[23]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[24]  A. Nikitin,et al.  Prostate stem cells and cancer. , 2007, Histology and histopathology.

[25]  D. Altieri Validating survivin as a cancer therapeutic target , 2003, Nature Reviews Cancer.

[26]  S. Lang,et al.  Prostate cancer stem cells , 2009, The Journal of pathology.

[27]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[28]  Chun-Peng Liao,et al.  A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. , 2008, Cancer research.

[29]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[30]  Wei Shi,et al.  Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. , 2007, Cancer research.

[31]  N. Maitland,et al.  Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  Feng Yang,et al.  Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. , 2005, Cancer research.

[33]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[34]  Jeffrey M. Rosen,et al.  The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.

[35]  I. Ng,et al.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.

[36]  O. Witte,et al.  Self‐Renewal and Multilineage Differentiation In Vitro from Murine Prostate Stem Cells , 2007, Stem cells.

[37]  L. Zon,et al.  Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.

[38]  O. Witte,et al.  In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Irving L Weissman,et al.  The cancer stem cell hypothesis: a work in progress , 2006, Laboratory Investigation.

[40]  S. Rutella,et al.  Expression of CD133-1 and CD133-2 in ovarian cancer , 2007, International Journal of Gynecologic Cancer.